Lazard Research & Insights
September 15, 2026
Lazard Global Biopharmaceutical Leaders Study 2026
The global biopharmaceutical industry is navigating a reshaped operating environment in 2026.
Lazard Healthcare Services Leaders Study 2026
Healthcare leaders are entering 2026 with cautious optimism and a sharper focus on execution — even as the imperative to deploy capital remains intense.
Lazard Global Biopharmaceutical Leaders Study 2025
Biopharmaceutical and biotech investors ended the summer of 2025 amid heightened uncertainty and significant financial market pressures.
